Valeo will host a conference call to discuss its fourth quarter and year-end 2023 results and highlights on Tuesday January 30, 2024, at 8.30 am (ET). The telephone numbers to access the conference call are 416-764-8659 and 1-888-664-6392. An audio replay of the call will be available. The numbers to access the audio replay are 416-764-8677 and 1-888-390-0541 using the following access code (959607 #).
A live audio webcast of the conference call will be available via:
https://app.webinar.net/5z6nmw5MNAw
Financial Statements and MD&A
Valeo Pharma's financial statements and Management's Discussion and Analysis for the three month and twelve-month periods ended October 31, 2023, are available on SEDAR at www.sedar.com.
About Valeo Pharma
Valeo Pharma is a Canadian pharmaceutical company dedicated to the commercialization of innovative prescription products in Canada with a focus on Respiratory/Allergy, Ophthalmology and Hospital Specialty Products. Headquartered in Kirkland, Quebec Valeo Pharma has all the required capabilities and the full infrastructure to register and properly manage its growing product portfolio through all stages of commercialization. For more information, please visit www.valeopharma.com and follow us on LinkedIn and Twitter.